Goldman Sachs’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,021,177
Closed -$19M 4864
2020
Q3
$19M Buy
2,021,177
+356,220
+21% +$3.35M 0.01% 1505
2020
Q2
$12.7M Sell
1,664,957
-233,474
-12% -$1.79M ﹤0.01% 1800
2020
Q1
$11.7M Sell
1,898,431
-189,659
-9% -$1.17M ﹤0.01% 1701
2019
Q4
$25.4M Buy
2,088,090
+1,090,709
+109% +$13.3M 0.01% 1456
2019
Q3
$11.5M Buy
997,381
+885,345
+790% +$10.2M ﹤0.01% 1854
2019
Q2
$1.12M Sell
112,036
-80,615
-42% -$806K ﹤0.01% 3126
2019
Q1
$2.48M Sell
192,651
-38,573
-17% -$497K ﹤0.01% 2814
2018
Q4
$3.51M Buy
231,224
+48,526
+27% +$737K ﹤0.01% 2533
2018
Q3
$3.65M Buy
182,698
+30,971
+20% +$619K ﹤0.01% 2589
2018
Q2
$2.96M Sell
151,727
-17,300
-10% -$337K ﹤0.01% 2682
2018
Q1
$3.41M Sell
169,027
-62,628
-27% -$1.26M ﹤0.01% 2565
2017
Q4
$3.07M Sell
231,655
-399,816
-63% -$5.3M ﹤0.01% 2581
2017
Q3
$11.7M Buy
631,471
+71,881
+13% +$1.33M ﹤0.01% 1900
2017
Q2
$10.3M Sell
559,590
-48,390
-8% -$890K ﹤0.01% 1920
2017
Q1
$13.7M Buy
607,980
+376,139
+162% +$8.48M ﹤0.01% 1706
2016
Q4
$8.07M Buy
231,841
+166,728
+256% +$5.8M ﹤0.01% 1923
2016
Q3
$1.6M Sell
65,113
-20,750
-24% -$509K ﹤0.01% 2818
2016
Q2
$2.05M Sell
85,863
-192,188
-69% -$4.6M ﹤0.01% 2600
2016
Q1
$6.51M Buy
278,051
+102,061
+58% +$2.39M ﹤0.01% 1951
2015
Q4
$5.31M Buy
175,990
+34,610
+24% +$1.05M ﹤0.01% 2000
2015
Q3
$5.62M Sell
141,380
-40,472
-22% -$1.61M ﹤0.01% 1955
2015
Q2
$12.6M Buy
181,852
+114,248
+169% +$7.89M ﹤0.01% 1580
2015
Q1
$3.7M Buy
67,604
+3,998
+6% +$219K ﹤0.01% 2192
2014
Q4
$2.71M Sell
63,606
-32,117
-34% -$1.37M ﹤0.01% 2327
2014
Q3
$3.06M Buy
95,723
+35,448
+59% +$1.13M ﹤0.01% 2271
2014
Q2
$1.25M Sell
60,275
-138,650
-70% -$2.87M ﹤0.01% 2839
2014
Q1
$3.85M Buy
198,925
+66,594
+50% +$1.29M ﹤0.01% 2167
2013
Q4
$3.21M Buy
132,331
+54,180
+69% +$1.32M ﹤0.01% 2306
2013
Q3
$1.68M Buy
78,151
+13,859
+22% +$298K ﹤0.01% 2608
2013
Q2
$1.43M Buy
+64,292
New +$1.43M ﹤0.01% 2580